Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and pharmacology of single
administrations of AVI-6002, a post-exposure prophylaxis candidate treatment for Ebolavirus.